1. KPI-121 0.25%: A New Option for the Treatment of Dry Eye Disease. Issue 2 (2021) Authors: Beckman, Kenneth; Katz, James A; Majmudar, Parag A; Rostov, Audrey Talley Journal: Touch reviews in ophthalmology Issue: Volume 15:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19. (July 2021) Authors: Puskarich, Michael A.; Cummins, Nathan W.; Ingraham, Nicholas E.; Wacker, David A.; Reilkoff, Ronald A.; Driver, Brian E; Biros, Michelle H.; Bellolio, Fernanda; Chipman, Jeffrey G.; Nelson, Andrew C.; Beckman, Kenneth; Langlois, Ryan; Bold, Tyler; Aliota, Matthew T.; Schacker, Timothy W.; Voelke... Journal: EClinicalMedicine Issue: Volume 37(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia. Issue 1 (December 2016) Authors: Fingerlin, Tasha; Zhang, Weiming; Yang, Ivana; Ainsworth, Hannah; Russell, Pamela; Blumhagen, Rachel; Schwarz, Marvin; Brown, Kevin; Steele, Mark; Loyd, James; Cosgrove, Gregory; Lynch, David; Groshong, Steve; Collard, Harold; Wolters, Paul; Bradford, Williamson; Kossen, Karl; Seiwert, Scott; du ... Journal: BMC genetics Issue: Volume 17:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗